Additional Information
Book Details
Abstract
There is a difference in drug handbooks. From the leading name in nursing, Mosby’s 2014 Nursing Drug Reference makes it easy to find the latest and most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled — including 70 new entries on current drugs and drugs recently approved by the FDA. And no other drug handbook places a higher emphasis on patient safety. With a full-color design and an A to Z organization, this portable reference gives you the most complete information for each drug, including dosing, side effects, interactions, and administration. Updated by nursing pharmacology expert Linda Skidmore-Roth, Mosby’s Nursing Drug Reference is a bestseller that has been relied upon by nurses for over 25 years.
- More than 5,000 generic and trade-name drugs are profiled, covering almost every drug you will administer in practice or in clinicals.
- Attractive full-color design highlights important information for quick and easy access.
- Black Box Warnings provide alerts to dangerous or life-threatening adverse reactions.
- Safety Alert icon identifies situations that require special attention.
- Common and life-threatening side effects are organized by body system, showing signs to watch for during assessments.
- Nursing Process steps are used as the framework for organizing all nursing care information.
- Coverage of IV drug administration highlights dosage and IV administration instructions, including special considerations and Y-site, syringe, and additive compatibilities.
- Comprehensive drug monographs include generic names, Rx or OTC availability, pronunciations, U.S. and Canadian trade names, functional and chemical classification, controlled-substance schedule, do-not-confuse drugs, action, uses, unlabeled uses, dosages and routes, available forms, side effects, contraindications, precautions, pharmacokinetics, interactions (including drug/herb, drug/food and drug lab test), nursing considerations, and treatment of overdose.
- Complete pharmacokinetic information includes the mechanism and absorption of the drug as well as its action, duration, and excretion.
- Flexible, water-resistant cover provides durability in the clinical setting.
- A companion website includes updates with infrequently used or recently approved drugs, a full-color pill atlas, guidelines to safe handling of chemotherapeutic agents, combination products, drugs metabolized by known P450s, medications to be cautiously for geriatric patients, herbal products, a listing of high-alert Canadian medications and immunization schedules, patient teaching guides in English and Spanish, and more.
- 70 NEW monographs provide up-to-date content on added or newly released drugs.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front cover | Cover | ||
How to use | ifc1 | ||
Evolve learning system | ifc | ||
Front matter | i | ||
Copyright | iv | ||
Consultants | v | ||
Preface | vii | ||
New features | vii | ||
New facts | vii | ||
Organization | vii | ||
Individual drug monographs | vii | ||
Appendixes | viii | ||
Table of contents | xi | ||
Table of contents for e page | e1 | ||
Drug categories | 1 | ||
A | 55 | ||
Abacavir (Rx) | 55 | ||
Abatacept (Rx) | 56 | ||
Abciximab (Rx) | 58 | ||
Abiraterone | 58 | ||
Acamprosate | 60 | ||
Acarbose (Rx) | 61 | ||
Acetaminophen (OTC) | 62 | ||
Acetazolamide (Rx) | 64 | ||
Acetylcholine ophthalmic | 67 | ||
Acetylcysteine (Rx) | 67 | ||
Aclidinium | 69 | ||
Activated charcoal (OTC) | 70 | ||
Acyclovir (Rx) | 71 | ||
Adalimumab (Rx) | 74 | ||
Adefovir (Rx) | 76 | ||
Adenosine (Rx) | 77 | ||
Aflibercept | 78 | ||
Albumin, human 5% (Rx) | 80 | ||
Albumin, human 25% | 80 | ||
Albuterol (Rx) | 81 | ||
Alendronate (Rx) | 83 | ||
Alfuzosin (Rx) | 85 | ||
Aliskiren (Rx) | 86 | ||
Allopurinol (Rx) | 87 | ||
Almotriptan (Rx) | 89 | ||
Alosetron | 90 | ||
Alprazolam (Rx) | 92 | ||
Controlled substance schedule IV | 92 | ||
Action: | 92 | ||
Uses: | 92 | ||
Contraindications: | 92 | ||
Dosage and routes | 92 | ||
Side effects | 92 | ||
Pharmacokinetics | 92 | ||
Interactions | 93 | ||
Nursing considerations | 93 | ||
Treatment of overdose: | 93 | ||
Alprostadil (Rx) | 93 | ||
Alteplase (tissue plasminogen activator, t-PA) (Rx) | 94 | ||
Aluminum hydroxide (OTC) | 96 | ||
Alvimopan | 98 | ||
Amantadine (Rx) | 99 | ||
Ambrisentan (Rx) | 100 | ||
Amifostine (Rx) | 101 | ||
Amikacin (Rx) | 103 | ||
Amiloride (Rx) | 106 | ||
Amino acids | 108 | ||
Amino acid infusions (crystalline) | 108 | ||
Amino acid infusions/dextrose | 108 | ||
Aminosyn with electrolytes | 108 | ||
Amino acid infusions/electrolytes/dextrose | 108 | ||
Amino acid infusions (hepatic failure) | 108 | ||
Amino acid infusions (high metabolic atress) | 108 | ||
Amino acid infusions (renal failure) | 108 | ||
Amiodarone (Rx) | 110 | ||
Amitriptyline (Rx) | 112 | ||
Amlodipine (Rx) | 114 | ||
Amoxicillin (Rx) | 116 | ||
Amoxicillin/clavulanate (Rx) | 118 | ||
Amphotericin B lipid complex | 120 | ||
Amphotericin B liposomal (LAmB) | 122 | ||
Ampicillin (Rx) | 124 | ||
Ampicillin, sulbactam (Rx) | 127 | ||
Anakinra (Rx) | 129 | ||
Anastrozole (Rx) | 130 | ||
Anidulafungin (Rx) | 131 | ||
Antithymocyte | 133 | ||
Apomorphine | 133 | ||
Apraclonidine ophthalmic | 135 | ||
Aprepitant (Rx) | 135 | ||
Fosaprepitant | 135 | ||
Arformoterol (Rx) | 137 | ||
Argatroban (Rx) | 138 | ||
Aripiprazole (Rx) | 140 | ||
Armodafinil (Rx) | 142 | ||
Controlled substance schedule IV | 142 | ||
Uses: | 142 | ||
Contraindications: | 142 | ||
Dosage and routes | 142 | ||
Ascorbic acid (vit C) (OTC, Rx) | 142 | ||
Asenapine (Rx) | 143 | ||
Asparaginase (Rx) | 145 | ||
Asparaginase erwinia chrysanthemi | 145 | ||
Aspirin (OTC) | 147 | ||
Atazanavir (Rx) | 150 | ||
Atenolol (Rx) | 151 | ||
Atomoxetine (Rx) | 153 | ||
Atorvastatin (Rx) | 155 | ||
Atovaquone (Rx) | 156 | ||
Atovaquone/proguanil | 157 | ||
Atracurium (Rx) | 158 | ||
Atropine (Rx) | 159 | ||
Atropine ophthalmic | 160 | ||
Auranofin (Rx) | 161 | ||
Avanafil | 161 | ||
Axitinib | 162 | ||
Azacitidine (Rx) | 164 | ||
Azathioprine (Rx) | 166 | ||
Azelaic acid | 167 | ||
Azelastine (ophthalmic) | 168 | ||
Azelastine nasal agent | 169 | ||
Azilsartan | 169 | ||
Azithromycin (Rx) | 170 | ||
Azithromycin ophthalmic | 172 | ||
Aztreonam (Rx) | 173 | ||
B | 173 | ||
Baclofen (Rx) | 173 | ||
Basiliximab (Rx) | 175 | ||
Beclomethasone (Rx) | 176 | ||
Beclomethasone (nasal) | 177 | ||
Belatacept | 179 | ||
Belimumab | 181 | ||
Benazepril (Rx) | 182 | ||
Bendamustine (Rx) | 184 | ||
Benzocaine topical | 186 | ||
Benzonatate (Rx) | 186 | ||
Benztropine (Rx) | 186 | ||
Bepotastine | 187 | ||
Beractant (Rx) | 188 | ||
Betamethasone (topical) | 189 | ||
Betamethasone dipropionate | 189 | ||
Betamethasone augmented dipropionate betamethasone valerate | 189 | ||
Betamethasone (augmented) topical | 189 | ||
Betaxolol (ophthalmic) | 189 | ||
Bethanechol (Rx) | 190 | ||
Bevacizumab (Rx) | 191 | ||
Bicalutamide (Rx) | 193 | ||
Bimatoprost (ophthalmic/topical) | 194 | ||
Bisacodyl (Rx, OTC) | 196 | ||
Bismuth subsalicylate (OTC) | 197 | ||
Bisoprolol (Rx) | 198 | ||
Bivalirudin (Rx) | 200 | ||
Bleomycin (Rx) | 202 | ||
Boceprevir | 205 | ||
Boric acid otic | 207 | ||
Bortezomib (Rx) | 207 | ||
Bosentan (Rx) | 208 | ||
Brentuximab | 210 | ||
Brimonidine (ophthalmic) | 211 | ||
Brinzolamide ophthalmic | 212 | ||
Bromfenac (ophthalmic) | 212 | ||
Bromocriptine (Rx) | 213 | ||
Budesonide (Rx) | 215 | ||
Budesonide nasal agent | 216 | ||
Bumetanide (Rx) | 216 | ||
Buprenorphine (Rx) | 219 | ||
Controlled substance schedule V (parenteral); schedule III (tablet, TD) | 219 | ||
Action: | 219 | ||
Uses: | 219 | ||
Contraindications: | 219 | ||
Dosage and routes | 219 | ||
Side effects | 220 | ||
Pharmacokinetics | 221 | ||
Interactions | 221 | ||
Nursing considerations | 221 | ||
Treatment of overdose: | 221 | ||
Bupropion (Rx) | 221 | ||
Buspirone (Rx) | 223 | ||
Busulfan (Rx) | 225 | ||
Butoconazole vaginal antifungal | 227 | ||
Butorphanol (Rx) | 227 | ||
Controlled substance schedule IV | 227 | ||
Action: | 227 | ||
Uses: | 227 | ||
Contraindications: | 227 | ||
Dosage and routes | 227 | ||
Side effects | 229 | ||
Pharmacokinetics | 229 | ||
Interactions | 229 | ||
Nursing considerations | 229 | ||
Treatment of overdose: | 229 | ||
C | 230 | ||
Calcitonin (rDNA) (Rx) | 230 | ||
Calcitonin (salmon) (Rx) | 230 | ||
Calcitriol vitamin D3 (Rx) | 231 | ||
Calcium carbonate (PO-OTC) | 233 | ||
Calcium acetate (OTC) | 233 | ||
Calcium chloride (Rx) | 235 | ||
Calcium gluceptate (Rx) | 235 | ||
Calcium gluconate (Rx) | 235 | ||
Calcium lactate (Rx) | 235 | ||
Calfactant (Rx) | 237 | ||
Candesartan (Rx) | 237 | ||
Capecitabine (Rx) | 238 | ||
Captopril (Rx) | 241 | ||
Carbachol ophthalmic | 243 | ||
Carbamazepine (Rx) | 243 | ||
Carboplatin (Rx) | 245 | ||
Carboprost (Rx) | 248 | ||
Carglumic acid | 249 | ||
Carisoprodol (Rx) | 250 | ||
Carmustine (Rx) | 251 | ||
Carteolol (ophthalmic) | 253 | ||
Carvedilol (Rx) | 255 | ||
Caspofungin (Rx) | 257 | ||
Cefaclor | 258 | ||
Cefadroxil | 258 | ||
Cefazolin | 258 | ||
Cefdinir | 258 | ||
Cefditoren pivoxil | 258 | ||
Cefepime | 258 | ||
Cefixime | 258 | ||
Cefotaxime | 258 | ||
Cefotetan | 258 | ||
Cefoxitin | 258 | ||
Cefpodoxime | 258 | ||
Cefprozil | 258 | ||
Ceftazidime | 258 | ||
Ceftibuten | 258 | ||
Ceftizoxime | 258 | ||
Ceftriaxone | 258 | ||
Cefuroxime | 258 | ||
Ceftaroline (Rx) | 259 | ||
Celecoxib (Rx) | 260 | ||
Cephalexin | 262 | ||
Cefadroxil (Rx) | 262 | ||
Cefazolin (Rx) | 262 | ||
Cephalexin (Rx) | 262 | ||
Cefaclor (Rx) | 265 | ||
Cefotetan (Rx) | 265 | ||
Cefoxitin (Rx) | 265 | ||
Cefprozil (Rx) | 265 | ||
Cefuroxime (Rx) | 265 | ||
Cefdinir (Rx) | 269 | ||
Cefditoren pivoxil (Rx) | 269 | ||
Cefepime (Rx) | 269 | ||
Cefixime (Rx) | 269 | ||
Cefotaxime (Rx) | 269 | ||
Cefpodoxime (Rx) | 269 | ||
Ceftazidime (Rx) | 269 | ||
Ceftibuten (Rx) | 269 | ||
Ceftizoxime (Rx) | 269 | ||
Ceftriaxone (Rx) | 269 | ||
Cephradine | 277 | ||
Certolizumab pegol (Rx) | 277 | ||
Cetirizine (Rx, OTC) | 279 | ||
Cetrorelix (Rx) | 280 | ||
Cetuximab (Rx) | 281 | ||
Chlordiazepoxide (Rx) | 283 | ||
Controlled substance schedule IV | 283 | ||
Action: | 283 | ||
Uses: | 283 | ||
Contraindications: | 283 | ||
Dosage and routes | 283 | ||
Side effects | 283 | ||
Pharmacokinetics | 284 | ||
Interactions | 284 | ||
Nursing considerations | 284 | ||
Treatment of overdose: | 284 | ||
Chloroquine (Rx) | 285 | ||
Chlorpheniramine (OTC, Rx) | 286 | ||
Chlorpromazine (Rx) | 288 | ||
Cholestyramine (Rx) | 291 | ||
Cidofovir (Rx) | 292 | ||
Cilostazol (Rx) | 294 | ||
Cimetidine (OTC, Rx) | 295 | ||
Cinacalcet (Rx) | 298 | ||
Ciprofloxacin (Rx) | 299 | ||
Ciprofloxacin (ophthalmic) | 301 | ||
Cisatracurium | 302 | ||
Cisplatin (Rx) | 304 | ||
Citalopram (Rx) | 307 | ||
Clarithromycin (Rx) | 309 | ||
Clevidipine (Rx) | 310 | ||
Clindamycin HCI (Rx) | 311 | ||
Clindamycin palmitate (Rx) | 311 | ||
Clindamycin phosphate (Rx) | 311 | ||
Clindamycin (topical, vaginal) | 314 | ||
Clobetasol | 316 | ||
Clomiphene (Rx) | 317 | ||
Clomipramine (Rx) | 318 | ||
Clonazepam (Rx) | 320 | ||
Controlled substance schedule IV | 320 | ||
Action: | 320 | ||
Uses: | 320 | ||
Contraindications: | 320 | ||
Dosage and routes | 320 | ||
Side effects | 320 | ||
Pharmacokinetics | 321 | ||
Interactions | 321 | ||
Nursing considerations | 321 | ||
Treatment of overdose: | 321 | ||
Clonidine (Rx) | 322 | ||
Clopidogrel (Rx) | 324 | ||
Clotrimazole (topical, vaginal, oral) | 325 | ||
Clozapine (Rx) | 326 | ||
Codeine (Rx) | 329 | ||
Controlled substance schedule II, III, IV, V (depends on content) | 329 | ||
Action: | 329 | ||
Uses: | 329 | ||
Contraindications: | 329 | ||
Dosage and routes | 329 | ||
Side effects | 329 | ||
Pharmacokinetics | 330 | ||
Interactions | 330 | ||
Nursing considerations | 330 | ||
Treatment of overdose: | 330 | ||
Colchicine (Rx) | 330 | ||
Colesevelam (Rx) | 332 | ||
Conivaptan (Rx) | 333 | ||
Contraceptives, hormonal | 334 | ||
Crizotinib | 338 | ||
Cromolyn (OTC, Rx) | 341 | ||
Crotamiton | 342 | ||
Cyanocobalamin (vit B12) (OTC, Rx) | 343 | ||
Hydroxocobalamin (OTC, Rx) | 343 | ||
Cyclobenzaprine (Rx) | 345 | ||
Cyclopentolate ophthalmic | 346 | ||
Cyclophosphamide (Rx) | 346 | ||
Cyclosporine (Rx) | 349 | ||
Cytarabine (Rx) | 353 | ||
Cytarabine liposomal (Rx) | 353 | ||
D | 356 | ||
Dabigatran | 356 | ||
Dacarbazine (Rx) | 357 | ||
Dalfampridine (Rx) | 359 | ||
Dalteparin (Rx) | 360 | ||
Dantrolene (Rx) | 362 | ||
Dapiprazole ophthalmic | 364 | ||
Daptomycin (Rx) | 364 | ||
Darbepoetin (Rx) | 366 | ||
Darifenacin | 367 | ||
Darunavir (Rx) | 368 | ||
Dasatinib (Rx) | 370 | ||
Daunorubicin (Rx) | 371 | ||
Daunorubicin citrate liposomal (Rx) | 371 | ||
Deferasirox (Rx) | 374 | ||
Degarelix | 374 | ||
Delavirdine (Rx) | 376 | ||
Demecarium ophthalmic | 377 | ||
Denosumab (Rx) | 377 | ||
Desipramine (Rx) | 379 | ||
Desirudin | 381 | ||
Desloratadine (Rx) | 382 | ||
Desmopressin (Rx) | 383 | ||
Desonide topical | 384 | ||
Desoximetasone | 384 | ||
Desoxyephedrine nasal agent | 385 | ||
Desvenlafaxine | 385 | ||
Dexamethasone (Rx) | 386 | ||
Dexamethasone sodium phosphate (Rx) | 386 | ||
Dexamethasone (ophthalmic) | 390 | ||
Dexamethasone topical | 390 | ||
Dexlansoprazole (Rx) | 390 | ||
Dexmethylphenidate (Rx) | 392 | ||
Controlled substance schedule II | 392 | ||
Action: | 392 | ||
Uses: | 392 | ||
Contraindications: | 392 | ||
Dosage and routes | 392 | ||
Side effects | 392 | ||
Pharmacokinetics | 392 | ||
Interactions | 393 | ||
Nursing considerations | 393 | ||
Treatment of overdose: | 393 | ||
Dextroamphetamine (Rx) | 393 | ||
Controlled substance schedule II | 393 | ||
Action: | 393 | ||
Uses: | 393 | ||
Contraindications: | 393 | ||
Dosage and routes | 394 | ||
Side effects | 394 | ||
Pharmacokinetics | 394 | ||
Interactions | 394 | ||
Nursing considerations | 395 | ||
Treatment of overdose: | 395 | ||
Dextromethorphan (OTC) | 395 | ||
Dextrose (D-glucose) (Rx) | 396 | ||
Diazepam (Rx) | 397 | ||
Controlled substance schedule IV | 397 | ||
Action: | 397 | ||
Uses: | 397 | ||
Contraindications: | 397 | ||
Dosage and routes | 398 | ||
Side effects | 398 | ||
Pharmacokinetics | 398 | ||
Interactions | 399 | ||
Nursing considerations | 399 | ||
Treatment of overdose: | 399 | ||
Dibucaine topical | 399 | ||
Diclofenac epolamine (Rx) | 400 | ||
Diclofenac potassium (Rx) | 400 | ||
Diclofenac sodium (Rx) | 400 | ||
Diclofenac ophthalmic | 402 | ||
Dicyclomine (Rx) | 402 | ||
Didanosine (Rx) | 403 | ||
Diflunisal | 405 | ||
Difluprednate (ophthalmic) | 405 | ||
Digoxin (Rx) | 406 | ||
Digoxin immune FAB (ovine) (Rx) | 411 | ||
Diltiazem (Rx) | 412 | ||
Dimenhydrinate (OTC, Rx) | 414 | ||
Motion sickness | 414 | ||
Dinoprostone (Rx) | 415 | ||
Diphenhydramine (OTC, Rx) | 417 | ||
Diphenoxylate/atropine (Rx) | 419 | ||
Difenoxin/atropine (Rx) | 419 | ||
Controlled substance schedule V | 419 | ||
Controlled substance schedule IV | 419 | ||
Action: | 419 | ||
Uses: | 419 | ||
Contraindications: | 419 | ||
Dosage and routes | 420 | ||
Side effects | 420 | ||
Pharmacokinetics | 420 | ||
Interactions | 420 | ||
Nursing considerations | 420 | ||
Dipivefrin ophthalmic | 420 | ||
Dipyridamole (Rx) | 420 | ||
Dobutamine (Rx) | 422 | ||
Docetaxel (Rx) | 424 | ||
Docosanol topical | 427 | ||
Docusate calcium (OTC) | 427 | ||
Docusate sodium (OTC) | 427 | ||
Dofetilide (Rx) | 428 | ||
Dolasetron (Rx) | 430 | ||
Donepezil (Rx) | 431 | ||
Dopamine (Rx) | 432 | ||
Doripenem (Rx) | 435 | ||
Dorzolamide (ophthalmic) | 437 | ||
Doxapram (Rx) | 437 | ||
Doxazosin (Rx) | 439 | ||
Doxepin (Rx) | 440 | ||
Doxorubicin | 442 | ||
Doxorubicin liposomal | 445 | ||
Doxycycline (Rx) | 447 | ||
Doxycycline calcium | 447 | ||
Doxycycline hyclate | 447 | ||
Doxycycline monohydrate | 447 | ||
Dronedarone (Rx) | 450 | ||
Droperidol (Rx) | 451 | ||
Duloxetine (Rx) | 453 | ||
Dutasteride (Rx) | 455 | ||
E | 456 | ||
Ecallantide | 456 | ||
Econazole | 456 | ||
Econazole topical | 457 | ||
Ecothiophate ophthalmic | 457 | ||
Edetate calcium disodium (Rx) | 457 | ||
Efavirenz (Rx) | 458 | ||
Eletriptan (Rx) | 459 | ||
Eltrombopag | 460 | ||
Emedastine ophthalmic | 460 | ||
Emtricitabine (Rx) | 460 | ||
Enalapril/enalaprilat (Rx) | 462 | ||
Enfuvirtide (Rx) | 464 | ||
Enoxaparin (Rx) | 465 | ||
Entacapone (Rx) | 467 | ||
Entecavir (Rx) | 468 | ||
Ephedrine nasal agent | 470 | ||
Epinastine (ophthalmic) | 470 | ||
Epinephrine (Rx) | 471 | ||
Epinephrine HCL | 471 | ||
Epinephrine/epinephryl borate ophthalmic | 474 | ||
Epinephrine nasal agent | 474 | ||
Epirubicin (Rx) | 474 | ||
Eplerenone (Rx) | 477 | ||
Epoetin alfa (Rx) | 478 | ||
Eprosartan (Rx) | 481 | ||
Eptifibatide (Rx) | 482 | ||
Eribulin | 484 | ||
Erlotinib (Rx) | 485 | ||
Ertapenem (Rx) | 487 | ||
Erythromycin | 489 | ||
Erythromycin base (Rx) | 490 | ||
Erythromycin ethylsuccinate (Rx) | 490 | ||
Erythromycin lactobionate (Rx) | 490 | ||
Erythromycin stearate (Rx) | 490 | ||
Erythromycin (topical) | 494 | ||
Escitalopram (Rx) | 495 | ||
Esmolol (Rx) | 497 | ||
Esomeprazole (Rx) | 499 | ||
Estradiol (Rx) | 500 | ||
Estradiol cypionate (Rx) | 500 | ||
Estradiol gel (Rx) | 500 | ||
Estradiol spray (Rx) | 500 | ||
Estradiol topical emulsion (Rx) | 500 | ||
Estradiol valerate (Rx) | 500 | ||
Estradiol transdermal system (Rx) | 500 | ||
Estradiol vaginal tablet (Rx) | 500 | ||
Estradiol vaginal ring (Rx) | 500 | ||
Estramustine (Rx) | 503 | ||
Estrogens, conjugated (Rx) | 503 | ||
Estrogens, conjugated synthetic B (Rx) | 503 | ||
Estropipate | 505 | ||
Eszopiclone (Rx) | 505 | ||
Controlled substance schedule IV | 505 | ||
Action: | 505 | ||
Uses: | 505 | ||
Contraindications: | 505 | ||
Dosage and routes | 505 | ||
Side effects | 506 | ||
Pharmacokinetics | 506 | ||
Interactions | 506 | ||
Nursing considerations | 506 | ||
Etanercept (Rx) | 506 | ||
Ethambutol (Rx) | 507 | ||
Etodolac | 508 | ||
Etomidate (Rx) | 510 | ||
Etoposide (Rx) | 510 | ||
Etoposide phosphate (Rx) | 510 | ||
Etravirine (Rx) | 513 | ||
Everolimus (Rx) | 515 | ||
Exemestane (Rx) | 517 | ||
Exenatide (Rx) | 518 | ||
Ezetimibe (Rx) | 520 | ||
Ezogabine | 521 | ||
F | 522 | ||
Factor IX complex (human) (Rx) | 522 | ||
Famciclovir (Rx) | 524 | ||
Famotidine (OTC, Rx) | 525 | ||
Fat emulsions (Rx) | 527 | ||
Febuxostat (Rx) | 528 | ||
Felodipine (Rx) | 529 | ||
Fenofibrate (Rx) | 531 | ||
Fentanyl (Rx) | 532 | ||
Fentanyl transdermal (Rx) | 532 | ||
Fentanyl nasal spray (Rx) | 532 | ||
Fentanyl SL spray | 532 | ||
Controlled substance schedule II | 532 | ||
Action: | 532 | ||
Uses: | 532 | ||
Contraindications: | 532 | ||
Dosage and routes | 533 | ||
Fentanyl | 533 | ||
Anesthetic | 533 | ||
G | 587 | ||
Gabapentin (Rx) | 587 | ||
Galantamine (Rx) | 589 | ||
Ganciclovir (Rx) | 590 | ||
Ganciclovir ophthalmic | 592 | ||
Gatifloxacin | 592 | ||
Gefitinib (Rx) | 593 | ||
Gemcitabine (Rx) | 594 | ||
Gemfibrozil (Rx) | 596 | ||
Gemifloxacin (Rx) | 597 | ||
Gentamicin (Rx) | 599 | ||
Gentamicin (ophthalmic) | 601 | ||
Gentamicin (topical) | 602 | ||
Glatiramer (Rx) | 603 | ||
Glimepiride (Rx) | 604 | ||
Glipizide (Rx) | 604 | ||
Glucagon | 606 | ||
Glucarpidase | 607 | ||
Glyburide (Rx) | 608 | ||
Glycerin (OTC) | 610 | ||
Golimumab (Rx) | 610 | ||
Goserelin (Rx) | 611 | ||
Granisetron (Rx) | 613 | ||
Guaifenesin (OTC, Rx) | 615 | ||
H | 615 | ||
Halcinonide topical | 615 | ||
Haloperidol (Rx) | 616 | ||
Haloperidol decanoate (Rx) | 616 | ||
Haloperidol lactate (Rx) | 616 | ||
Heparin (Rx) | 618 | ||
Hepatitis B immune globulin (HBIG) (Rx) | 621 | ||
Homatropine ophthalmic | 622 | ||
Hydralazine (Rx) | 622 | ||
Hydrochlorothiazide (Rx) | 624 | ||
Hydrocodone (Rx) | 625 | ||
Hydrocodone/acetaminophen (Rx) | 625 | ||
Hydrocodone/ibuprofen (Rx) | 625 | ||
Controlled substance schedule III | 625 | ||
Action: | 625 | ||
Uses: | 625 | ||
Contraindications: | 626 | ||
Dosage and routes | 626 | ||
Side effects | 626 | ||
Pharmacokinetics | 626 | ||
Interactions | 626 | ||
Nursing considerations | 626 | ||
Treatment of overdose: | 627 | ||
Hydrocortisone (Rx) | 627 | ||
Hydrocortisone acetate (Rx) | 627 | ||
Hydrocortisone sodium succinate (Rx) | 627 | ||
Hydrocortisone nasal | 629 | ||
Hydrocortisone (topical) | 630 | ||
Hydrocortisone acetate | 630 | ||
Hydrocortisone butyrate | 630 | ||
Hydrocortisone probutate | 630 | ||
Hydrocortisone valerate | 630 | ||
Hydromorphone (Rx) | 631 | ||
Controlled substance schedule II | 631 | ||
Action: | 631 | ||
Uses: | 631 | ||
Contraindications: | 631 | ||
Dosage and routes | 631 | ||
Side effects | 632 | ||
Pharmacokinetics | 632 | ||
Interactions | 632 | ||
Nursing considerations | 633 | ||
Treatment of overdose: | 633 | ||
Hydroxychloroquine (Rx) | 633 | ||
Hydroxyurea (Rx) | 635 | ||
Hydroxyzine (Rx) | 637 | ||
Hyoscyamine (Rx) | 638 | ||
I | 640 | ||
Ibandronate (Rx) | 640 | ||
Ibritumomab (Rx) | 641 | ||
Ibuprofen (OTC, Rx) | 643 | ||
Ibuprofen lysine (Rx) | 643 | ||
Ibutilide (Rx) | 645 | ||
Idarubicin (Rx) | 646 | ||
Ifosfamide (Rx) | 648 | ||
Iloperidone (Rx) | 650 | ||
Imatinib (Rx) | 652 | ||
Imipenem/cilastatin (Rx) | 655 | ||
Imipramine (Rx) | 657 | ||
Immune globulin IM (IMIG/IGIM) (Rx) | 660 | ||
Immune globulin IV (IGIV, IVIG) (Rx) | 660 | ||
Immune globulin SC (SCIG/IGSC) | 660 | ||
Indacaterol | 662 | ||
Indapamide (Rx) | 664 | ||
Indinavir (Rx) | 665 | ||
Indomethacin (Rx) | 667 | ||
Infliximab (Rx) | 668 | ||
Insulins | 670 | ||
Rapid acting | 670 | ||
Insulin glulisine (Rx) | 670 | ||
Insulin aspart (Rx) | 670 | ||
Insulin lispro (Rx) | 670 | ||
Short acting | 670 | ||
Insulin, regular (OTC) | 670 | ||
Insulin, regular concentrated (Rx) | 670 | ||
Intermediate acting | 670 | ||
Insulin, isophane suspension (NPH) (OTC) | 670 | ||
Long acting | 670 | ||
Insulin detemir (Rx) | 670 | ||
Insulin glargine (Rx) | 670 | ||
Mixtures | 670 | ||
Insulin, isophane suspension and regular insulin (Rx) | 670 | ||
Isophane insulin suspension (NPH) and insulin mixtures (Rx) | 671 | ||
Insulin lispro mixture (Rx) | 671 | ||
Insulin aspart mixture (Rx) | 671 | ||
Interferon alfacon-1 (Rx) | 674 | ||
Interferon beta-1a (Rx) | 675 | ||
Interferon beta-1b (Rx) | 675 | ||
Interferon gamma-1b (Rx) | 680 | ||
Ipilimumab | 681 | ||
Ipratropium (Rx) | 682 | ||
Irbesartan (Rx) | 684 | ||
Irinotecan (Rx) | 685 | ||
Iron dextran (Rx) | 687 | ||
Iron sucrose (Rx) | 688 | ||
Isoflurophate ophthalmic | 689 | ||
Isoniazid (Rx) | 689 | ||
Isosorbide dinitrate (Rx) | 691 | ||
Isosorbide mononitrate (Rx) | 691 | ||
Isotretinoin (Rx) | 692 | ||
Itraconazole (Rx) | 692 | ||
Ixabepilone (Rx) | 694 | ||
K | 696 | ||
Ketoconazole (Rx) | 696 | ||
Ketoconazole (topical) | 697 | ||
Ketoprofen (OTC, Rx) | 698 | ||
Ketorolac (ophthalmic) | 700 | ||
Ketorolac (systemic, nasal) (Rx) | 701 | ||
Ketotifen (ophthalmic) | 703 | ||
L | 704 | ||
Labetalol (Rx) | 704 | ||
Lacosamide (Rx) | 706 | ||
Lactulose (Rx) | 707 | ||
Lamivudine 3TC (Rx) | 708 | ||
Lamotrigine (Rx) | 710 | ||
Lansoprazole (Rx, OTC) | 712 | ||
Lanthanum (Rx) | 713 | ||
Lapatinib (Rx) | 714 | ||
Latanoprost (ophthalmic) | 715 | ||
Leflunomide (Rx) | 716 | ||
Letrozole (Rx) | 718 | ||
Leucovorin (Rx) | 719 | ||
Leuprolide (Rx) | 720 | ||
Levalbuterol (Rx) | 722 | ||
Levetiracetam (Rx) | 723 | ||
Levobetaxolol ophthalmic | 725 | ||
Levobunolol (ophthalmic) | 725 | ||
Levocabastine ophthalmic | 726 | ||
Levocetirizine (Rx) | 726 | ||
Levodopa-carbidopa (Rx) | 727 | ||
Levofloxacin (Rx) | 729 | ||
Levofloxacin ophthalmic | 732 | ||
Levothyroxine (T4) (Rx) | 732 | ||
Lidocaine (parenteral) (Rx) | 734 | ||
Lidocaine topical | 736 | ||
Linagliptin | 736 | ||
Lindane (Rx) | 737 | ||
Linezolid (Rx) | 739 | ||
Liothyronine (T3) (Rx) | 741 | ||
Liotrix (Rx) | 742 | ||
Liraglutide (Rx) | 744 | ||
Lisdexamfetamine (Rx) | 745 | ||
Controlled substance schedule II | 745 | ||
Action: | 745 | ||
Uses: | 745 | ||
Contraindications: | 745 | ||
Dosage and routes | 746 | ||
Side effects | 746 | ||
Pharmacokinetics | 746 | ||
Interactions | 746 | ||
Nursing considerations | 746 | ||
Treatment of overdose: | 747 | ||
Lisinopril (Rx) | 747 | ||
Lithium (Rx) | 748 | ||
Lodoxamide ophthalmic | 750 | ||
Loperamide (OTC, Rx) | 750 | ||
Lopinavir/ritonavir | 751 | ||
Loratadine (OTC, Rx) | 754 | ||
Lorazepam (Rx) | 755 | ||
Controlled substance schedule IV | 755 | ||
Action: | 755 | ||
Uses: | 755 | ||
Contraindications: | 755 | ||
Dosage and routes | 755 | ||
Side effects | 756 | ||
Pharmacokinetics | 756 | ||
Interactions | 756 | ||
Nursing considerations | 756 | ||
Treatment of overdose: | 757 | ||
Losartan | 757 | ||
Loteprednol ophthalmic | 758 | ||
Lovastatin (Rx) | 759 | ||
Loxapine (Rx) | 760 | ||
Lubiprostone (Rx) | 762 | ||
Lurasidone (Rx) | 763 | ||
Lymphocyte immune globulin (anti-thymocyte, equine) (Rx) | 764 | ||
M | 765 | ||
Mafenide topical | 765 | ||
Magnesium salts | 765 | ||
Magnesium chloride (Rx) | 765 | ||
Magnesium citrate (OTC) magnesium gluconate (OTC) | 765 | ||
Magnesium oxide (OTC) | 765 | ||
Magnesium hydroxide (OTC) | 765 | ||
Magnesium sulfate (OTC, Rx) | 765 | ||
Mannitol (Rx) | 767 | ||
Maraviroc (Rx) | 769 | ||
Mebendazole (Rx) | 771 | ||
Mecasermin (Rx) | 772 | ||
Meclizine (OTC, Rx) | 773 | ||
Medroxyprogesterone (Rx) | 774 | ||
Medrysone ophthalmic | 776 | ||
Megestrol (Rx) | 776 | ||
Melphalan (Rx) | 777 | ||
Memantine (Rx) | 780 | ||
Meperidine (Rx) | 781 | ||
Controlled substance schedule II | 781 | ||
Action: | 781 | ||
Uses: | 781 | ||
Contraindications: | 781 | ||
Dosage and routes | 781 | ||
Side effects | 782 | ||
Pharmacokinetics | 782 | ||
Interactions | 782 | ||
Nursing considerations | 782 | ||
Treatment of overdose: | 783 | ||
Mercaptopurine (6-MP) (Rx) | 783 | ||
Meropenem (Rx) | 785 | ||
Mesalamine, 5-ASA (Rx) | 786 | ||
Metformin (Rx) | 788 | ||
Methadone (Rx) | 790 | ||
Controlled substance schedule II | 790 | ||
Action: | 790 | ||
Uses: | 790 | ||
Contraindications: | 790 | ||
Dosage and routes | 790 | ||
Side effects | 790 | ||
Pharmacokinetics | 790 | ||
Interactions | 790 | ||
Nursing considerations | 791 | ||
Treatment of overdose: | 791 | ||
Methimazole (Rx) | 792 | ||
Methotrexate (Rx) | 793 | ||
Methylcellulose (OTC) | 797 | ||
Methyldopa/methyldopate (Rx) | 798 | ||
Methylergonovine (Rx) | 800 | ||
Methylnaltrexone (Rx) | 801 | ||
Methylphenidate (Rx) | 802 | ||
Controlled substance schedule II | 802 | ||
Action: | 802 | ||
Uses: | 802 | ||
Contraindications: | 802 | ||
Dosage and routes | 802 | ||
Side effects | 804 | ||
Pharmacokinetics | 804 | ||
Interactions | 804 | ||
Nursing considerations | 804 | ||
Treatment of overdose: | 805 | ||
Methylprednisolone (Rx) | 805 | ||
Metipranolol ophthalmic | 807 | ||
Metoclopramide (Rx) | 808 | ||
Metolazone (Rx) | 810 | ||
Metoprolol (Rx) | 811 | ||
Metronidazole (Rx) | 814 | ||
Metronidazole (topical, vaginal) | 817 | ||
Micafungin (Rx) | 818 | ||
Miconazole | 820 | ||
Miconazole nitrate | 820 | ||
Midazolam (Rx) | 821 | ||
Controlled substance schedule IV | 821 | ||
Action: | 821 | ||
Uses: | 821 | ||
Contraindications: | 821 | ||
Dosage and routes | 821 | ||
Side effects | 822 | ||
Pharmacokinetics | 822 | ||
Interactions | 822 | ||
Nursing considerations | 823 | ||
Treatment of overdose: | 823 | ||
Miglitol (Rx) | 823 | ||
Milrinone (Rx) | 824 | ||
Minocycline (Rx) | 826 | ||
Minoxidil (Rx, OTC) | 828 | ||
Mirtazapine (Rx) | 829 | ||
Misoprostol (Rx) | 831 | ||
Mitomycin (Rx) | 832 | ||
Mitoxantrone (Rx) | 834 | ||
Modafinil (Rx) | 836 | ||
Controlled substance IV | 836 | ||
Action: | 836 | ||
Uses: | 837 | ||
Contraindications: | 837 | ||
Dosage and routes | 837 | ||
Side effects | 837 | ||
Pharmacokinetics | 837 | ||
Interactions | 837 | ||
Nursing considerations | 837 | ||
Montelukast (Rx) | 838 | ||
Morphine (Rx) | 839 | ||
Controlled substance schedule II | 839 | ||
Action: | 839 | ||
Uses: | 839 | ||
Contraindications: | 839 | ||
Dosage and routes | 839 | ||
Side effects | 842 | ||
Pharmacokinetics | 842 | ||
Interactions | 842 | ||
Nursing considerations | 843 | ||
Treatment of overdose: | 843 | ||
Moxifloxacin (Rx) | 843 | ||
Moxifloxacin (ophthalmic) | 845 | ||
Mupirocin (topical, nasal) | 846 | ||
Mycophenolate mofetil (Rx) | 847 | ||
N | 849 | ||
Nabumetone (Rx) | 849 | ||
Nadolol (Rx) | 850 | ||
Nafcillin (Rx) | 852 | ||
Nalbuphine (Rx) | 853 | ||
Naloxone (Rx) | 855 | ||
Naltrexone (Rx) | 857 | ||
Naphazoline nasal agent | 858 | ||
Naphazoline (ophthalmic) | 858 | ||
Naproxen (Rx, OTC) | 859 | ||
Naratriptan (Rx) | 861 | ||
Natalizumab (Rx) | 862 | ||
Natamycin ophthalmic | 864 | ||
Nebivolol (Rx) | 864 | ||
Nelfinavir ( Rx) | 865 | ||
Neomycin (Rx) | 867 | ||
Neomycin topical | 867 | ||
Nepafenac ophthalmic | 867 | ||
Nesiritide (Rx) | 867 | ||
Nevirapine (Rx) | 869 | ||
Niacin (OTC, Rx) | 871 | ||
Niacinamide (OTC, Rx) | 871 | ||
Nicardipine (Rx) | 872 | ||
Nicotine | 874 | ||
Nicotine chewing gum | 874 | ||
Nicotine inhaler (OTC, Rx) | 874 | ||
Nicotine lozenge (OTC) | 874 | ||
Nicotine nasal spray (Rx) | 874 | ||
Nicotine transdermal (OTC, Rx) | 874 | ||
Nifedipine (Rx) | 876 | ||
Nilotinib (Rx) | 878 | ||
Nisoldipine (Rx) | 880 | ||
Nitazoxanide (Rx) | 881 | ||
Nitrofurantoin (Rx) | 882 | ||
Nitrofurazone topical | 883 | ||
Nitroglycerin (Rx) | 884 | ||
Extended release caps (Rx) | 884 | ||
Topical ointment (Rx) | 884 | ||
Rectal ointment | 884 | ||
SL (Rx) | 884 | ||
Translingual spray (Rx) | 884 | ||
Transdermal (Rx) | 884 | ||
Nitroprusside (Rx) | 886 | ||
Nizatidine (OTC, Rx) | 888 | ||
Norepinephrine (Rx) | 889 | ||
Norethindrone (Rx) | 891 | ||
Norfloxacin ophthalmic | 892 | ||
Nortriptyline (Rx) | 893 | ||
Nystatin (Rx) | 895 | ||
Nystatin topical | 895 | ||
Nystatin vaginal antifungal | 896 | ||
O | 896 | ||
Octreotide (Rx) | 896 | ||
Ofloxacin (Rx) | 898 | ||
Ofloxacin ophthalmic | 898 | ||
Olanzapine (Rx) | 900 | ||
Olmesartan (Rx) | 902 | ||
Olopatadine nasal agent | 904 | ||
Olopatadine ophthalmic | 904 | ||
Olsalazine (Rx) | 904 | ||
Omalizumab (Rx) | 905 | ||
Omeprazole (OTC, Rx) | 906 | ||
Ondansetron (Rx) | 907 | ||
Orlistat (Rx, OTC) | 909 | ||
Oseltamivir (Rx) | 910 | ||
Oxaliplatin (Rx) | 912 | ||
Oxazepam (Rx) | 915 | ||
Controlled substance schedule IV | 915 | ||
Action: | 915 | ||
Uses: | 915 | ||
Contraindications: | 915 | ||
Dosage and routes | 915 | ||
Side effects | 915 | ||
Pharmacokinetics | 915 | ||
Interactions | 915 | ||
Nursing considerations | 915 | ||
Oxcarbazepine (Rx) | 916 | ||
Oxybutynin (Rx) | 917 | ||
Oxycodone (Rx) | 919 | ||
Oxycodone/aspirin (Rx) | 919 | ||
Oxycodone/acetaminophen (Rx) | 919 | ||
Oxycodone/ibuprofen (Rx) | 919 | ||
Controlled substance schedule II | 919 | ||
Action: | 919 | ||
Uses: | 919 | ||
Contraindications: | 919 | ||
Dosage and routes | 920 | ||
Side effects | 920 | ||
Pharmacokinetics | 921 | ||
Interactions | 921 | ||
Nursing considerations | 921 | ||
Treatment of overdose: | 921 | ||
Oxymetazoline nasal agent | 921 | ||
Oxymetazoline ophthalmic | 921 | ||
Oxymorphone (Rx) | 922 | ||
Controlled substance schedule II | 922 | ||
Action: | 922 | ||
Uses: | 922 | ||
Contraindications: | 922 | ||
Dosage and routes | 922 | ||
Side effects | 922 | ||
Pharmacokinetics | 922 | ||
Interactions | 923 | ||
Nursing considerations | 923 | ||
Treatment of overdose: | 923 | ||
Oxytocin (Rx) | 923 | ||
P | 925 | ||
Paclitaxel (Rx) | 925 | ||
Paclitaxel nanoparticle albumin-bound (Rx) | 925 | ||
Paliperidone (Rx) | 928 | ||
Palonosetron (Rx) | 930 | ||
Pamidronate (Rx) | 931 | ||
Pancrelipase (Rx) | 934 | ||
Pancuronium (Rx) | 935 | ||
Panitumumab (Rx) | 936 | ||
Pantoprazole (Rx) | 937 | ||
Paricalcitol (Rx) | 940 | ||
Paroxetine (Rx) | 941 | ||
Pegfilgrastim (Rx) | 943 | ||
Peginterferon alfa-2a (Rx) | 944 | ||
Peginterferon alfa-2b (Rx) | 944 | ||
Pegloticase (Rx) | 946 | ||
Pemetrexed (Rx) | 947 | ||
Penciclovir topical | 950 | ||
Penicillin G benzathine (Rx) | 950 | ||
Penicillin G (Rx) | 950 | ||
Penicillin G procaine (Rx) | 950 | ||
Penicillin V (Rx) | 950 | ||
Pentamidine (Rx) | 953 | ||
Pentazocine (Rx) | 954 | ||
Controlled substance schedule IV | 954 | ||
Action: | 954 | ||
Uses: | 954 | ||
Contraindications: | 954 | ||
Dosage and routes | 955 | ||
Side effects | 955 | ||
Pharmacokinetics | 955 | ||
Interactions | 955 | ||
Nursing considerations | 955 | ||
Treatment of overdose: | 956 | ||
Pentoxifylline (Rx) | 956 | ||
Perindopril (Rx) | 957 | ||
Phenobarbital (Rx) | 958 | ||
Controlled substance schedule IV | 958 | ||
Action: | 958 | ||
Uses: | 958 | ||
Contraindications: | 959 | ||
Dosage and routes | 959 | ||
Side effects | 959 | ||
Pharmacokinetics | 959 | ||
Interactions | 959 | ||
Nursing considerations | 960 | ||
Phentolamine (Rx) | 960 | ||
Phenylephrine (Rx) | 961 | ||
Phenylephrine nasal agent | 963 | ||
Phenylephrine ophthalmic | 963 | ||
Phenytoin (Rx) | 963 | ||
Phosphate/biphosphate (OTC) | 965 | ||
Physostigmine ophthalmic | 966 | ||
Phytonadione (Rx) | 966 | ||
Pilocarpine ophthalmic | 967 | ||
Pimecrolimus topical | 967 | ||
Pioglitazone (Rx) | 967 | ||
Piperacillin/tazobactam (Rx) | 969 | ||
Pirbuterol (Rx) | 971 | ||
Pitavastatin (Rx) | 972 | ||
Plasma protein fraction (Rx) | 973 | ||
Plerixafor (Rx) | 974 | ||
Posaconazole (Rx) | 975 | ||
Potassium acetate | 977 | ||
Potassium bicarbonate (OTC, Rx) | 977 | ||
Potassium bicarbonate and potassium chloride (OTC, Rx) | 977 | ||
Potassium bicarbonate and potassium citrate (OTC, Rx) | 977 | ||
Potassium chloride (OTC, Rx) | 977 | ||
Potassium gluconate (OTC, Rx) | 977 | ||
Potassium iodide (Rx) | 979 | ||
Pramipexole (Rx) | 981 | ||
Pramlintide (Rx) | 982 | ||
Pramoxine topical | 983 | ||
Prasugrel (Rx) | 983 | ||
Pravastatin (Rx) | 984 | ||
Prazosin (Rx) | 986 | ||
Prednisolone (Rx) | 987 | ||
Prednisolone ophthalmic (Rx) | 988 | ||
Prednisone (Rx) | 988 | ||
Pregabalin (Rx) | 990 | ||
Controlled substance schedule V | 990 | ||
Action: | 990 | ||
Uses: | 990 | ||
Contraindications: | 990 | ||
Dosage and routes | 991 | ||
Side effects | 991 | ||
Pharmacokinetics | 991 | ||
Interactions | 991 | ||
Nursing considerations | 991 | ||
Treatment of overdose: | 992 | ||
Primaquine (Rx) | 992 | ||
Primidone (Rx) | 993 | ||
Probenecid (Rx) | 994 | ||
Procainamide (Rx) | 995 | ||
Procarbazine (Rx) | 998 | ||
Prochlorperazine (Rx) | 999 | ||
Progesterone (Rx) | 1001 | ||
Promethazine (Rx) | 1003 | ||
Propafenone (Rx) | 1006 | ||
Proparacaine ophthalmic | 1007 | ||
Propofol (Rx) | 1007 | ||
Propranolol (Rx) | 1009 | ||
Propylhexadrine nasal agent | 1012 | ||
Propylthiouracil (Rx) | 1012 | ||
Protamine (Rx) | 1014 | ||
Pseudoephedrine (OTC, Rx) | 1015 | ||
Pseudoephedrine nasal agent | 1016 | ||
Psyllium (OTC, Rx) | 1016 | ||
Pyridostigmine (Rx) | 1017 | ||
Pyridoxine (vit B6) (Rx, OTC) | 1019 | ||
Pyrimethamine (Rx) | 1020 | ||
Q | 1021 | ||
Quetiapine (Rx) | 1021 | ||
Quinapril (Rx) | 1024 | ||
Quinidine gluconate (Rx) | 1025 | ||
Quinidine sulfate (Rx) | 1025 | ||
R | 1028 | ||
Rabeprazole (Rx) | 1028 | ||
Radioactive iodine (sodium iodide) 131I (Rx) | 1029 | ||
Raloxifene (Rx) | 1031 | ||
Raltegravir (Rx) | 1032 | ||
Ramelteon (Rx) | 1033 | ||
Ramipril (Rx) | 1034 | ||
Ranibizumab (Rx) | 1036 | ||
Ranitidine (Rx, OTC) | 1037 | ||
Ranitidine bismuth citrate | 1037 | ||
Ranolazine (Rx) | 1039 | ||
Rasagiline (Rx) | 1041 | ||
Rasburicase (Rx) | 1042 | ||
Remifentanil (Rx) | 1043 | ||
Controlled substance schedule II | 1043 | ||
Action: | 1043 | ||
Uses: | 1043 | ||
Contraindications: | 1043 | ||
Dosage and routes | 1043 | ||
Side effects | 1044 | ||
Pharmacokinetics | 1044 | ||
Interactions | 1044 | ||
Nursing considerations | 1044 | ||
Repaglinide (Rx) | 1045 | ||
Retapamulin (topical) | 1046 | ||
Rho(D) immune globulin standard dose IM (Rx) | 1047 | ||
Rho(D) immune globulin microdose IM (Rx) | 1047 | ||
Rho(D) immune globulin IV (Rx) | 1047 | ||
Riboflavin (vit B2) (OTC) | 1049 | ||
Rifabutin (Rx) | 1050 | ||
Rifampin (Rx) | 1051 | ||
Rifapentine (Rx) | 1053 | ||
Rifaximin (Rx) | 1054 | ||
Rilpivirine | 1055 | ||
Riluzole (Rx) | 1057 | ||
Rimantadine (Rx) | 1058 | ||
Rimexolone ophthalmic | 1059 | ||
Risedronate (Rx) | 1059 | ||
Risperidone (Rx) | 1060 | ||
Ritonavir (Rx) | 1064 | ||
Rituximab (Rx) | 1066 | ||
Rivaroxaban | 1068 | ||
Rivastigmine (Rx) | 1070 | ||
Rizatriptan (Rx) | 1072 | ||
Roflumilast | 1073 | ||
Romiplostim (Rx) | 1074 | ||
Ropinirole (Rx) | 1076 | ||
Rosiglitazone (Rx) | 1077 | ||
Rosuvastatin (Rx) | 1079 | ||
Rufinamide (Rx) | 1080 | ||
S | 1081 | ||
Salicylic acid topical | 1081 | ||
Salmeterol (Rx) | 1081 | ||
Sargramostim (GM-CSF) (Rx) | 1083 | ||
Saxagliptin (Rx) | 1085 | ||
Scopolamine (Rx) | 1086 | ||
Scopolamine ophthalmic | 1087 | ||
Selegiline (Rx) | 1087 | ||
Selenium topical | 1089 | ||
Sertraline (Rx) | 1089 | ||
Sildenafil (Rx) | 1091 | ||
Silodosin (Rx) | 1093 | ||
Silver nitrate 1% ophthalmic | 1094 | ||
Silver nitrate 1% sulfacetamide sodium ophthalmic | 1094 | ||
Silver sulfadiazine topical | 1094 | ||
Simethicone (OTC, Rx) | 1094 | ||
Simvastatin (Rx) | 1095 | ||
Sirolimus (Rx) | 1096 | ||
Sitagliptin (Rx) | 1098 | ||
Sodium bicarbonate (Rx, OTC) | 1099 | ||
Sodium polystyrene sulfonate (Rx) | 1101 | ||
Solifenacin (Rx) | 1103 | ||
Somatropin (Rx) | 1104 | ||
Sotalol (Rx) | 1110 | ||
Spironolactone (Rx) | 1112 | ||
Stavudine d4t (Rx) | 1114 | ||
Succinylcholine (Rx) | 1115 | ||
Sucralfate (Rx) | 1117 | ||
Sulfasalazine (Rx) | 1118 | ||
Sumatriptan (Rx) | 1120 | ||
Sunitinib (Rx) | 1121 | ||
Suprofen ophthalmic | 1123 | ||
T | 1123 | ||
Tacrolimus (Rx) (PO, IV) | 1123 | ||
Tacrolimus (topical) (Rx) | 1123 | ||
Tadalafil (Rx) | 1126 | ||
Tamoxifen (Rx) | 1127 | ||
Tamsulosin (Rx) | 1129 | ||
Tapentadol (Rx) | 1130 | ||
Controlled substance schedule II | 1130 | ||
Action: | 1130 | ||
Uses: | 1130 | ||
Contraindications: | 1130 | ||
Dosage and routes | 1131 | ||
Side effects | 1131 | ||
Pharmacokinetics | 1131 | ||
Interactions | 1131 | ||
Nursing considerations | 1131 | ||
Telaprevir | 1132 | ||
Telavancin (Rx) | 1134 | ||
Telbivudine (Rx) | 1136 | ||
Telmisartan (Rx) | 1137 | ||
Temazepam (Rx) | 1138 | ||
Controlled substance schedule IV (USA), schedule F (Canada) | 1138 | ||
Action: | 1138 | ||
Uses: | 1138 | ||
Contraindications: | 1138 | ||
Dosage and routes | 1138 | ||
Side effects | 1138 | ||
Pharmacokinetics | 1138 | ||
Interactions | 1138 | ||
Nursing considerations | 1139 | ||
Treatment of overdose: | 1139 | ||
Temozolomide (Rx) | 1139 | ||
Temsirolimus (Rx) | 1141 | ||
Tenecteplase (TNK-tPa)(Rx) | 1142 | ||
Tenofovir (Rx) | 1144 | ||
Terazosin (Rx) | 1145 | ||
Terbinafine oral (Rx) | 1146 | ||
Terbinafine topical | 1146 | ||
Terbutaline (Rx) | 1147 | ||
Terconazole vaginal antifungal | 1147 | ||
Teriparatide (Rx) | 1149 | ||
Tesamorelin | 1150 | ||
Testosterone cypionate (Rx) | 1151 | ||
Testosterone enanthate (Rx) | 1151 | ||
Testosterone gel (Rx) | 1151 | ||
Testosterone pellets (Rx) | 1151 | ||
Testosterone transdermal (Rx) | 1151 | ||
Testosterone buccal (Rx) | 1151 | ||
Testosterone topical solution | 1151 | ||
Controlled substance schedule III | 1151 | ||
Action: | 1151 | ||
Uses: | 1151 | ||
Contraindications: | 1152 | ||
Dosage and routes | 1152 | ||
Side effects | 1153 | ||
Pharmacokinetics | 1153 | ||
Interactions | 1153 | ||
Nursing considerations | 1153 | ||
Tetracaine ophthalmic | 1153 | ||
Tetracaine topical | 1153 | ||
Tetracycline (Rx) | 1154 | ||
Tetrahydrozoline nasal agent | 1154 | ||
Tetrahydrozoline ophthalmic | 1154 | ||
Theophylline (Rx) | 1155 | ||
Thiamine (vit B1) (PO-OTC; IV, IM-Rx) | 1159 | ||
Thioridazine (Rx) | 1160 | ||
Thyroid USP (desiccated) (Rx) | 1162 | ||
Tiagabine (Rx) | 1164 | ||
Ticagrelor | 1165 | ||
Ticarcillin/clavulanate (Rx) | 1166 | ||
Ticlopidine (Rx) | 1168 | ||
Tigecycline (Rx) | 1169 | ||
Timolol (Rx) | 1172 | ||
Timolol (ophthalmic) | 1173 | ||
Tinidazole (Rx) | 1175 | ||
Tinzaparin (Rx) | 1176 | ||
Tioconazole vaginal antifungal | 1177 | ||
Tiotropium (Rx) | 1178 | ||
Tipranavir (Rx) | 1179 | ||
Tirofiban (Rx) | 1180 | ||
Tizanidine (Rx) | 1182 | ||
Tobramycin (Rx) | 1183 | ||
Tobramycin ophthalmic | 1186 | ||
Tocilizumab (Rx) | 1186 | ||
Tolcapone (Rx) | 1187 | ||
Tolnaftate topical | 1188 | ||
Tolterodine (Rx) | 1188 | ||
Tolvaptan (Rx) | 1189 | ||
Topiramate (Rx) | 1191 | ||
Topotecan (Rx) | 1192 | ||
Toremifene (Rx) | 1194 | ||
Torsemide (Rx) | 1195 | ||
Tramadol (Rx) | 1197 | ||
Trandolapril (Rx) | 1199 | ||
Trastuzumab (Rx) | 1200 | ||
Travoprost ophthalmic | 1202 | ||
Trazodone (Rx) | 1202 | ||
Treprostinil (Rx) | 1204 | ||
Tretinoin (vit A acid, retinoic acid) (Rx) | 1205 | ||
Tretinoin topical | 1207 | ||
Triamcinolone (Rx) | 1207 | ||
Triamcinolone nasal agent | 1208 | ||
Triamcinolone ophthalmic | 1208 | ||
Triamcinolone (topical) | 1208 | ||
Triamcinolone (topical-oral) (otc) | 1209 | ||
Triazolam (Rx) | 1210 | ||
Controlled substance schedule IV (USA), targeted (CDSA IV) (Canada) | 1210 | ||
Action: | 1210 | ||
Uses: | 1210 | ||
Contraindications: | 1210 | ||
Dosage and routes | 1210 | ||
Side effects | 1210 | ||
Pharmacokinetics | 1210 | ||
Interactions | 1210 | ||
Nursing considerations | 1210 | ||
Treatment of overdose: | 1211 | ||
Trifluridine ophthalmic | 1211 | ||
Trimethobenzamide (Rx) | 1211 | ||
Trimethoprim-sulfamethoxazole (Rx) | 1212 | ||
Tropicamide ophthalmic | 1214 | ||
Trospium (Rx) | 1214 | ||
U | 1215 | ||
Undecylenic acid topical | 1215 | ||
Unoprostone ophthalmic | 1215 | ||
Ustekinumab (Rx) | 1215 | ||
V | 1216 | ||
Valacyclovir (Rx) | 1216 | ||
Valganciclovir (Rx) | 1218 | ||
Valproate (Rx) | 1219 | ||
Valproic acid (Rx) | 1219 | ||
Divalproex sodium (Rx) | 1219 | ||
Valsartan (Rx) | 1221 | ||
Vancomycin (Rx) | 1222 | ||
Vardenafil (Rx) | 1224 | ||
Varenicline (Rx) | 1225 | ||
Vasopressin (Rx) | 1227 | ||
Vemurafenib | 1228 | ||
Venlafaxine (Rx) | 1230 | ||
Verapamil (Rx) | 1232 | ||
Vidarabine ophthalmic | 1235 | ||
Vigabatrin (Rx) | 1235 | ||
Vilazodone (Rx) | 1236 | ||
Vinblastine (VLB) (Rx) | 1237 | ||
Vincristine (VCR) (Rx) | 1239 | ||
Vinorelbine (Rx) | 1241 | ||
Vitamin A (Rx, PO-OTC, Rx-IM) | 1243 | ||
Vitamin E (OTC) | 1245 | ||
Voriconazole (Rx) | 1245 | ||
W | 1248 | ||
Warfarin (Rx) | 1248 | ||
X | 1250 | ||
Xylometazoline nasal agent | 1250 | ||
Z | 1250 | ||
Zafirlukast (Rx) | 1250 | ||
Zaleplon (Rx) | 1251 | ||
Controlled substance schedule IV | 1251 | ||
Action: | 1251 | ||
Uses: | 1251 | ||
Contraindications: | 1251 | ||
Dosage and routes | 1252 | ||
Side effects | 1252 | ||
Pharmacokinetics | 1252 | ||
Interactions | 1252 | ||
Nursing considerations | 1252 | ||
Zanamivir (Rx) | 1252 | ||
Zidovudine (Rx) | 1253 | ||
Zinc (Rx, OTC) | 1255 | ||
Ziprasidone (Rx) | 1256 | ||
Zoledronic acid (Rx) | 1258 | ||
Zolmitriptan (Rx) | 1260 | ||
Zolpidem (Rx) | 1261 | ||
Controlled substance schedule IV | 1261 | ||
Action: | 1261 | ||
Uses: | 1261 | ||
Contraindications: | 1261 | ||
Dosage and routes | 1261 | ||
Side effects | 1262 | ||
Pharmacokinetics | 1262 | ||
Interactions | 1262 | ||
Nursing considerations | 1262 | ||
Treatment of overdose: | 1262 | ||
Zonisamide (Rx) | 1262 | ||
Recent FDA drug approvals | 1264 | ||
Appendix A Selected new drugs | 1265 | ||
Alogliptin | 1265 | ||
Bosutinib | 1266 | ||
Cabozantinib | 1267 | ||
Carfilzomib | 1268 | ||
Enzalutamide | 1270 | ||
Icosapent | 1271 | ||
Ivacaftor | 1272 | ||
Linaclotide | 1272 | ||
Lorcaserin | 1273 | ||
Lucinactant | 1273 | ||
Mirabegron | 1274 | ||
Ocriplasmin | 1274 | ||
Omacetaxine | 1275 | ||
Pazopanib | 1276 | ||
Peginesatide | 1277 | ||
Perampanel | 1279 | ||
Pertuzumab | 1280 | ||
Regorafenib | 1282 | ||
Tbo-filgrastim | 1283 | ||
Teriflunomide | 1284 | ||
Tofacitinib | 1285 | ||
Vismodegib | 1287 | ||
Ziv-aflibercept | 1288 | ||
Appendix B Ophthalmic, otic, nasal, and topical products | 1290 | ||
Appendix C Vaccines and toxoids | 1301 | ||
Integrated resources on pageburst | e | ||
Index | 1309 | ||
0–9, and symbols | 1309 | ||
A | 1309 | ||
B | 1315 | ||
C | 1317 | ||
D | 1322 | ||
E | 1325 | ||
F | 1327 | ||
G | 1328 | ||
H | 1330 | ||
I | 1334 | ||
J | 1335 | ||
K | 1336 | ||
L | 1336 | ||
M | 1338 | ||
N | 1341 | ||
O | 1343 | ||
P | 1345 | ||
Q | 1350 | ||
R | 1351 | ||
S | 1353 | ||
T | 1356 | ||
U | 1359 | ||
V | 1360 | ||
W | 1361 | ||
X | 1362 | ||
Y | 1362 | ||
Z | 1362 | ||
End sheets | 1363 | ||
Formulas | 1363 | ||
Surface area rule: | 1363 | ||
Calculating strength of a solution: | 1363 | ||
Calculating flow rate for IV: | 1363 | ||
Calculation of medication dosages: | 1363 | ||
Formula method: | 1363 | ||
Ratio–proportion method: | 1363 | ||
Dimensional analysis method: | 1363 | ||
Temperature conversion: | 1363 | ||
Nomogram for calculation of body surface area | 1364 | ||
Antitoxins and antivenins | ibc1 | ||
Abbreviations | ibc2 |